Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Amioxid-neuraxpharm
2. Amitriptyline N-oxide
3. Equilibrin
1. Amitriptyline N-oxide
2. Equilibrin
3. 4317-14-0
4. Ambivalon
5. Amitriptyline-n-oxide
6. Amitriptylinoxide [inn]
7. Amitriptyline Oxide
8. Tyr2u59wma
9. 1-propanamine, 3-(10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-ylidene)-n,n-dimethyl-n-oxide
10. 10,11-dihydro-n,n-dimethyl-5h-dibenzo(a,d)cycloheptene-delta(sup 5,gamma)-propylamine N-oxide
11. J9.621k
12. Amitriptylinoxide (inn)
13. Nsc176555
14. Amitriptilinoxido
15. Amitriptylinoxyde
16. Amitriptylinoxidum
17. Amitriptylinoxidum [inn-latin]
18. Amitriptylinoxyde [inn-french]
19. Amitriptilinoxido [inn-spanish]
20. Unii-tyr2u59wma
21. Brn 2385442
22. Amitriptylinoxid
23. Chembl627
24. Ncistruc1_001927
25. Ncistruc2_001301
26. 10,11-dihydro-n,n-dimethyl-5h-dibenzo(a,d)cycloheptene-delta5,gamma-propylamine-n-oxide
27. 3-(10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yliden)-n,n-dimethylpropylamin N-oxid
28. Amitryptyline-n-oxide
29. Schembl54518
30. Amitriptylinoxide [mi]
31. Dtxsid50195758
32. Chebi:135224
33. Amitriptylinoxide [who-dd]
34. Bdbm112778
35. Zinc1481969
36. Ccg-37141
37. Ncgc00014514
38. Nci176555
39. Db13114
40. 10,11-dihydro-n,n-dimethyl-5h-dibenzo(a,d)cycloheptene-delta5,gamma-propylamine N-oxide
41. 3-(10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5-ylidene)-n,n-dimethyl-1-propanamine N-oxide
42. Ncgc00014514-02
43. Ncgc00097618-01
44. 5h-dibenzo(a,d)cycloheptene-delta(sup 5),gamma-propylamine, 10,11-dihydro-n,n-dimethyl-n-oxide
45. N,n-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine Oxide
46. Nci60_001463
47. Us8629135, Sw-03
48. D07449
49. Q472476
50. Nortriptyline Hydrochloride Impurity J [ep Impurity]
51. (3-(10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5-ylidene)propyl)(hydroxy)dimethyl-5-azane
52. 3-(5,6-dihydrodibenzo[[?],[?]][7]annulen-11-ylidene)-n,n-dimethyl-propan-1-amine Oxide
53. (3-(10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5-ylidene)propyl)(hydroxy)dimethyl-.lambda.~5~-azane
54. 10,11-dihydro-n,n-dimethyl-5h-dibenzo[a,d]cycloheptene-.delta.5,.gamma.-propylamine N-oxide
55. 3-(10,11-dihydro-5h-dibenzo-[a,d]cyclohepten-5-ylidene)-n,n-dimethyl-1-propanamine N-oxide
56. 5h-dibenzo(a,d)cycloheptene-.delta.5,.gamma.-propylamine, 10,11-dihydro-n,n-dimethyl-n-oxide
| Molecular Weight | 293.4 g/mol |
|---|---|
| Molecular Formula | C20H23NO |
| XLogP3 | 4.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 3 |
| Exact Mass | 293.177964357 g/mol |
| Monoisotopic Mass | 293.177964357 g/mol |
| Topological Polar Surface Area | 18.1 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 375 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Amitriptylinoxide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amitriptylinoxide, including repackagers and relabelers. The FDA regulates Amitriptylinoxide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amitriptylinoxide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Amitriptylinoxide supplier is an individual or a company that provides Amitriptylinoxide active pharmaceutical ingredient (API) or Amitriptylinoxide finished formulations upon request. The Amitriptylinoxide suppliers may include Amitriptylinoxide API manufacturers, exporters, distributors and traders.
click here to find a list of Amitriptylinoxide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Amitriptylinoxide written confirmation (Amitriptylinoxide WC) is an official document issued by a regulatory agency to a Amitriptylinoxide manufacturer, verifying that the manufacturing facility of a Amitriptylinoxide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Amitriptylinoxide APIs or Amitriptylinoxide finished pharmaceutical products to another nation, regulatory agencies frequently require a Amitriptylinoxide WC (written confirmation) as part of the regulatory process.
click here to find a list of Amitriptylinoxide suppliers with Written Confirmation (WC) on PharmaCompass.
Amitriptylinoxide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amitriptylinoxide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amitriptylinoxide GMP manufacturer or Amitriptylinoxide GMP API supplier for your needs.
A Amitriptylinoxide CoA (Certificate of Analysis) is a formal document that attests to Amitriptylinoxide's compliance with Amitriptylinoxide specifications and serves as a tool for batch-level quality control.
Amitriptylinoxide CoA mostly includes findings from lab analyses of a specific batch. For each Amitriptylinoxide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amitriptylinoxide may be tested according to a variety of international standards, such as European Pharmacopoeia (Amitriptylinoxide EP), Amitriptylinoxide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amitriptylinoxide USP).
LOOKING FOR A SUPPLIER?
